July 27, 2026
mayank
Aditya Birla (ABSL) Pharma & Healthcare Fund
| Fund at a Glance | |
| NAV Growth (Rs.) | 40.36 |
| NAV Bonus (Rs.) | — |
| NAV IDCW (Rs.) | 26.24 |
| Min. Investment (Rs.) | 1,000 |
| Min. SIP Investment (Rs.) | 100 |
| Min. No of Cheques | 6 |
| Benchmark | BSE Healthcare TRI |
| AUM Rs. | 1,011 Cr |
| (As on 30-Jun-2026) | |
| Expense | 0.82% |
| 1 Year Return (%) | 17.50 |
| 3 Year Return (%) | 23.93 |
| 5 Year Return (%) | 15.22 |
| 10 Year Return (%) | — |
| Return Since Launch | 21.93% |
Suitable For Which Investors?
Pharma funds are suitable for investors:
1. Wanting a small, supporting exposure to the pharmaceutical and healthcare sector
2. Aiming for long term wealth creation
3. With a 7+ year investment horizon, who can withstand the sharper swings of a concentrated portfolio
Note:
• Most investors can skip these funds and stick to diversified equity funds instead
• If you choose to invest, do so only through SIP
Fund’s Investment Strategy:
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
Fund Manager:
1) Dhaval Shah
Education: Mr.Shah has done B.Com. from University of Mumbai & MBA from Somaiya Institute of Management Studies & Research. He also holds CFA designation.
Experience: Prior to joining Aditya Birla Sunlife Mutual Fund he has worked with HDFC Mutual Fund, Reliance Mutual Fund, Morgan Stanley.
Investment Details
| Min. Investment (Rs) | 1,000 |
| Min. Addl Investment (Rs) | 1,000 |
| Min. SIP Investment (Rs) | 100 |
| Min. Withdrawal (Rs) | 1 |
| Min. No of Cheques | 6 |
| Min. Balance (Rs) | 500 |
| Lock-in Period | NA |
| Exit Load | 1% for redemption within 30 days |
Basic Details of Aditya Birla (ABSL) Pharma & Healthcare Fund
| Fund House | Aditya Birla Sun Life Mutual Fund |
| Launch Date | 10-Jul-19 |
| Return Since Launch | 21.93% |
| Benchmark | BSE Healthcare TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | 1,011 Cr |
| (As on 30-Jun-2026) | |
| Expense | 0.82% |
| (As on 30-Jun-2026) | |
| Risk Grade | Above Average |
| Return Grade | Average |
| Turnover | 22.00% |
Aditya Birla (ABSL) Pharma & Healthcare Fund Trailing Returns (%)
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| ABSL Pharma & Healthcare Dir | 19.13 | 0.70 | 7.43 | 17.60 | 23.27 | 17.50 | 23.93 | 15.22 | 21.95 | — |
| BSE Healthcare TRI | 15.63 | 0.24 | 5.61 | 16.39 | 22.45 | 12.81 | 24.33 | 14.82 | 22.45 | — |
| Equity: Sectoral-Pharma | 16.50 | 0.34 | 5.87 | 16.15 | 22.34 | 14.58 | 23.07 | 15.36 | 23.99 | — |
| Rank within category | 6 | 1 | 2 | 7 | 12 | 6 | 5 | 6 | 8 | — |
| Number of funds in category | 24 | 25 | 25 | 25 | 24 | 23 | 13 | 10 | 9 | 4 |
Peer Comparison of Aditya Birla Pharma & Healthcare Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| ABSL Pharma & Healthcare Dir | 3 out of 5 stars | 17.50 | 23.93 | 15.22 | 0.82 | 1,011 | 21.93 | 1.00 (30) | 7Y | 22.00 |
| ICICI Pru Pharma Healthcare and Diagnostics Dir | 4 out of 5 stars | 9.01 | 25.62 | 16.98 | 0.86 | 6,625 | 21.48 | 1.00 (15) | 8Y | 69.00 |
| SBI Healthcare Opportunities Dir | 5 out of 5 stars | 17.32 | 24.74 | 18.01 | 0.76 | 4,998 | 18.32 | 0.50 (15) | 13Y 6M | 33.00 |
| UTI Healthcare Dir | 4 out of 5 stars | 14.45 | 26.31 | 15.81 | 1.01 | 1,308 | 16.55 | 1.00 (30) | 13Y 6M | 30.00 |
| Nippon India Pharma Dir | 3 out of 5 stars | 9.86 | 20.87 | 13.88 | 0.79 | 9,044 | 17.74 | 1.00 (30) | 13Y 6M | 15.00 |
Aditya Birla (ABSL) Pharma & Healthcare FundPortfolio Analysis
| No. of Stocks | 38 |
| Top 10 Stocks (*) | –% |
| Top 5 Stocks (*) | –% |
| Top 3 Sectors (*) | –% |
| Portfolio P/B Ratio (*) | 6.01 |
| Portfolio P/E Ratio | 41.65 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 60,151 | 83,976 |
| Large (%) | 29.33 | 33.09 |
| Mid (%) | 33.35 | 42.13 |
| Small (%) | 37.32 | 27.79 |
Note: Mutual fund investments are subject to market risks, read all scheme-related documents carefully.
Apply Online: https://mutualfund.adityabirlacapital.com/help-centre/invest-now OR
https://mutualfund.adityabirlacapital.com/portal/investor/login
>> Post your MF questions @ sahifund.com/ask-me/
>> NFO Guidance: https://sahifund.com/category/nfos/
Quicklinks